NCT02777515

Brief Summary

Justification Smoking is a major factor for mortality and cardiovascular morbidity. The electronic cigarette, sometimes presented as smoking cessation "classic" is expanding but its safety has not been established to date. The smoke from the electronic cigarette is mainly composed of propylene glycol, some adverse effects were observed in animals. Study Type interventional study assessing the effect of the electronic cigarette Inclusion criteria Topics under 35 years presenting to Rhythm of the consultation for a cardiovascular evaluation and already smoking the electronic cigarette and that for at least 1 month Exclusion criteria

  • Consumption of traditional cigarettes, nicotine replacement or toxic
  • Presence of heart disease Primary objective To evaluate in a pilot study the immediate cardiovascular effects of electronic cigarette consumption Number of patients 20 Duration of Study Recruitment in 2015 for an unlimited period of inclusion. Exam time is about two hours. Procedures performed during the study Physical examination, ECG, Holter-ECG 10 minutes and echocardiography were performed before and 15 minutes after the consumption of the usual electronic cigarette of the subject. No additional follow-up visit is required

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable cardiovascular-diseases

Timeline
Completed

Started Oct 2015

Shorter than P25 for not_applicable cardiovascular-diseases

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 30, 2015

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 5, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 9, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 19, 2016

Completed
13 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
Last Updated

May 30, 2018

Status Verified

May 1, 2018

Enrollment Period

1 month

First QC Date

May 9, 2016

Last Update Submit

May 25, 2018

Conditions

Keywords

electronic cigarette

Outcome Measures

Primary Outcomes (4)

  • Assessment of change of blood pressure

    before smoking then 15 min after smoking

  • Assessment of change of Electrocardiogram (ECG)

    before smoking then 15 min after smoking

  • Assessment of change of Holter-ECG

    before smoking then 15 min after smoking

  • Assessment of change of transthoracic echocardiogram

    before smoking then 15 min after smoking

Study Arms (1)

Patients using electronic cigarette

OTHER

The patients under the age of 35 followed at the consultation of rythmology for a cardiovascular assessment and already smoking the electronic cigarette and this since at least 1 month. The patient will receive a clinical examination, an electrocardiogram, a Holter-ECG and an echocardiogram before and after electronic cigarette consumption for 15 minutes.

Behavioral: using electronic cigarette

Interventions

Assesment of patients, using electronic cigarette, presenting to the Rhythm of consultation for a cardiovascular evaluation by: 1. A compendium of history, a general physical examination (weight, height) and cardiovascular with measurement of oxygen saturation, an assessment of past and current smoking (with documentation of the concentration of nicotine in the electronic cigarette and the product brand used) 2. measurement of blood pressure 3. An electrocardiogram 4. A Holter-ECG 10 minutes 5. A transthoracic echocardiogram

Patients using electronic cigarette

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged under 35 years
  • Having no known heart disease
  • Not consuming any toxic
  • Already smoking the electronic cigarette and that for at least one month to ensure good tolerance of the electronic cigarette

You may not qualify if:

  • Subjects also smoking a conventional cigarette or using other nicotine substitutes will be excluded

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Groupe Hospitalier Paris Saint Joseph

Paris, Île-de-France Region, 75014, France

Location

MeSH Terms

Conditions

Cardiovascular DiseasesVaping

Condition Hierarchy (Ancestors)

SmokingBehavior

Study Officials

  • Ghassan MOUBARAK, MD

    Groupe Hospitalier Paris Saint-Joseph (FRANCE)

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 9, 2016

First Posted

May 19, 2016

Study Start

October 30, 2015

Primary Completion

December 5, 2015

Study Completion

June 1, 2016

Last Updated

May 30, 2018

Record last verified: 2018-05

Locations